Search

Byline: Matthew Fazelpoor Jersey City-based Organon is expanding its distribution and promotion agreement with Eli Lilly and Co. for migraine medicine Emgality. Emgality, a monoclonal antibody that selectively binds to [...]

NATICK: Pillar Biosciences, Inc has issued the following press release: Pillar Biosciences, Inc. has entered into a strategic partnership with AstraZeneca to expand laboratory access to molecular testing, using rapid, [...]

Byline: Ojoma Akor Roche, a leading multinational healthcare company has announced the signing of a strategic agreement with Oncopadi, a provider of digital integrated healthcare services. A statement from Roche [...]

Partnership aims to make liquid biopsy tumor profiling more accessible to local laboratories, clinicians and patients through rapid, affordable, kitted NGS testing solutions. NATICK, Mass., Sept. 10, 2024 /PRNewswire/ -- [...]

(GLOBE NEWSWIRE via COMTEX) -- Collaboration Provides Streamlined Communications and Efficiencies to Pharmaceutical and Biotech Manufacturers Commercializing SHL Drug Delivery Solutions Morrisville, North Carolina USA, and Zug, Switzerland, Sept. 04, [...]

Venlo, the Netherlands, Aug. 28, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its Master Collaboration Agreement with AstraZeneca to develop and [...]

Collaboration leverages Quotient's platform to identify somatic mutations in genes that modify the progression of cardiovascular and renal diseases Quotient and Pioneering Medicines, Flagship's in-house drug development unit, will jointly [...]

SAN FRANCISCO, Calif. -- Harvey is thrilled to announce a new integration with Icertis, the global leader in AI-powered contract intelligence. This partnership marks the first time Harvey's domain-specific models [...]

* Malaria is a life-threatening public health issue, particularly in low- and middle-income countries. There is a need for an effective, affordable, and accessible preventive and/or treatment medication. This potential [...]

FARMINGTON HILLS: LSPedia has issued the following press release: LSPedia, a SaaS solution leader in global product traceability, proudly announces a strategic partnership with Pharma Logistics, the industry leader in [...]

FARMINGTON HILLS, Mich., Aug. 13, 2024 /PRNewswire/ -- LSPedia, a SaaS solution leader in global product traceability, proudly announces a strategic partnership with Pharma Logistics, the industry leader in pharmaceutical [...]

Tokyo: Eisai Co., Ltd. (ESALY) has issued the following press release: Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') and EcoNaviSta Inc. (Headquarters: Tokyo, President: Kimihito Watanabe, 'EcoNaviSta') announced [...]

TOKYO, July 25, 2024 - (JCN Newswire) - Eisai Co., Ltd. and EcoNaviSta Inc. announced today that they have entered into a business alliance agreement and commenced collaboration with the [...]

LAS VEGAS -- The following information was released by the National Association for the Advancement of Colored People (NAACP): Today, the National Association for the Advancement of Colored People (NAACP) [...]

GURUGRAM, India & NEW YORK -- Yatra Online, Inc. ('Company' or 'Yatra') (NASDAQ: YTRA) India's largest corporate travel services provider and one of India's leading online travel companies, today announced [...]

Byline: Kimberly Redmond Sanofi Consumer Healthcare-owned Xyzal is teaming up with iconic Asbury Park music festival Sea.Hear.Now. As part of the new collaboration, the 24-hour allergy relief medication will be [...]

California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the drug that can save someone’s life during an opioid overdose, under a deal [...]

M2 EQUITYBITES-September 12, 2024-Sanofi, RadioMedix and Orano Med partner on rare cancer treatment (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday a strategic [...]

M2 PHARMA-September 12, 2024-Sanofi, RadioMedix and Orano Med partner on rare cancer treatment (C)2024 M2 COMMUNICATIONS French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Thursday a strategic partnership [...]

M2 EQUITYBITES-September 4, 2024-HAYA Therapeutics partners with Eli Lilly for obesity drug discovery (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Precision medicines company HAYA Therapeutics SA announced on Wednesday that it has entered [...]

M2 EQUITYBITES-July 24, 2024-Charles River Laboratories and Autobahn Labs forge alliance to boost academic drug discovery (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Charles River Laboratories International Inc (NYSE: CRL) and Autobahn Labs, [...]

M2 PHARMA-July 24, 2024-Charles River Laboratories and Autobahn Labs forge alliance to boost academic drug discovery (C)2024 M2 COMMUNICATIONS Charles River Laboratories International Inc (NYSE: CRL) and Autobahn Labs, a [...]

M2 EQUITYBITES-July 3, 2024-India's Yatra Online Forms Domestic Travel Services Partnership with Cipla (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk Indian corporate travel services provider and online travel company Yatra Online, Inc. (NASDAQ: [...]

TOKYO: NIPPON EXPRESS HOLDINGS, INC has issued the following press release: NIPPON EXPRESS HOLDINGS, INC. has signed a strategic partnership agreement with Iceland-based Controlant, Inc., a leading provider of real-time [...]

- Set to Provide Real-time Monitoring Service for Tracking Cargo Location and Strict Temperature Control - TOKYO, June 25, 2024 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. has signed a strategic [...]

SALT LAKE CITY: USANA Health Sciences, Inc., a leader in global nutrition, has recently entered into a partnership agreement with the world-famous Jamaica Bobsleigh and Skeleton Federation (JBSF). The partnership [...]

Partnership will run through 2026 Winter Olympics SALT LAKE CITY, June 20, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in global nutrition, has recently entered into a partnership [...]

STOCKHOLM, June 19, 2024 /PRNewswire/ --Medivir AB (NASDAQ: MVIR) (STOCKHOLM: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today [...]

First exploration agreement initiated under strategic partnership between Flagship and Pfizer to accelerate the development of innovative medicines Collaboration leverages ProFound's proprietary ProFoundry(TM) Platform to identify potential novel protein therapeutics [...]